RFL - Rafael Holdings ends merger agreement with Rafael Pharmaceuticals
Rafael Holdings (NYSE:RFL) has terminated a merger agreement with Rafael Pharmaceuticals that was announced in June 2021. Rafael Holdings holds 51% of the outstanding capital stock of the latter, which is a private-owned late-stage oncology company. An SEC filing did not provide a reason for the breakup. Rafael Holdings "may seek to enter into discussions with Pharma regarding the relationship between the companies in light of the termination of the Merger Agreement," the filing stated. Rafael Holdings announced a CEO transition last month.
For further details see:
Rafael Holdings ends merger agreement with Rafael Pharmaceuticals